Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery

被引:67
作者
Krishnaiah, YSR [1 ]
Satyanarayana, S [1 ]
Prasad, YVR [1 ]
机构
[1] Andhra Univ, Dept Pharmaceut Sci, Waltair 530003, Andhra Pradesh, India
关键词
D O I
10.1081/DDC-100102221
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to develop colon-specific delivery systems for 5-aminosalicylic acid (5-ASA) using guar gum as a carrier, Core tablets containing 5-ASA were prepared by wet granulation with starch paste and were compression coated with coating formulations containing different quantities of guar gum (300, 200, 150, and 125 mg). In vitro drug release studies were carried out in simulated gastric and intestinal fluids and in pH 6.8 buffer containing rat cecal contents. The application of 175 mg of coating formulation containing 150 mg of guar gum over 5-ASA core tablets resulted in the release of less than 2% drug in simulated gastric and intestinal fluids and about 93% of 5-ASA in pH 6.8 buffer containing mt cecal contents, Differential scanning calorimetric (DSC) studies showed the absence of any interaction between 5-ASA and the excipients on storage at 45 degrees C for 12 weeks. The study confirmed that selective delivery of 5-ASA to the colon can he achieved using guar gum as a carrier in the form of a compression coating over the drug core.
引用
收藏
页码:651 / 657
页数:7
相关论文
共 30 条
[21]  
Rubinstein A., 1997, P INT S CONTR REL BI, V24, P839
[22]  
SCHACHT E, 1991, P INT S CONTR REL BI, V18, P686
[23]   Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon [J].
Tozaki, H ;
Komoike, J ;
Tada, C ;
Maruyama, T ;
Terabe, A ;
Suzuki, T ;
Yamamoto, A ;
Muranishi, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1016-1021
[24]   EFFECT OF SULFAPYRIDINE, 5-AMINOSALICYLIC ACID, AND PLACEBO IN PATIENTS WITH IDIOPATHIC PROCTITIS - A STUDY TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE [J].
VANHEES, PAM ;
BAKKER, JH ;
VANTONGEREN, JHM .
GUT, 1980, 21 (07) :632-635
[25]   In vitro degradation by colonic bacteria of inulinHP incorporated in Eudragit RS films [J].
Vervoort, L ;
Kinget, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :185-190
[26]   Pectin/ethylcellulose film coating formulations for colonic drug delivery [J].
Wakerly, Z ;
Fell, JT ;
Attwood, D ;
Parkins, D .
PHARMACEUTICAL RESEARCH, 1996, 13 (08) :1210-1212
[27]   ENCAPSULATION OF 5-AMINOSALICYLIC ACID INTO EUDRAGIT RS MICROSPHERES AND MODULATION OF THEIR RELEASE CHARACTERISTICS BY USE OF SURFACTANTS [J].
WATTS, PJ ;
DAVIES, MC ;
MELIA, CD .
JOURNAL OF CONTROLLED RELEASE, 1991, 16 (03) :311-318
[28]  
Whistler R. L., 1973, IND GUMS, V2nd, P303
[29]   USP Dissolution Apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulations [J].
Wong, D ;
Larrabee, S ;
Clifford, K ;
Tremblay, J ;
Friend, DR .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (02) :173-179
[30]   THE SPREADING OF FOAM AND SOLUTION ENEMAS [J].
WOOD, E ;
WILSON, CG ;
HARDY, JG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 25 (02) :191-197